About: CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes
Creator	Burnside, M Crocket, H De Bock, Martin Jefferies, & Lewis, & Paul, & Wheeler, B Williman, J Wilson, &
Source	PMC
abstract	BACKGROUND: Commercialised automated insulin delivery (AID) systems have demonstrated improved outcomes in type 1 diabetes (T1D), however, they have limited capacity for algorithm individualisation, and can be prohibitively expensive if an individual is without access to health insurance or health funding subsidy. Freely available open-source algorithms, which have the ability to individualise algorithm parameters paired with commercial insulin pumps, and continuous glucose monitoring make up the so-called %22do it yourself%22 (DIY) approach to AID. Limited data on the open-source approach have shown promising results, but data from a large randomised control trial are lacking. METHODS: The CREATE (Community deRivEd AutomaTEd insulin delivery) trial is an open-labelled, randomised, parallel 24-week, multi-site trial comparing sensor augmented pump therapy (SAPT) to our AnyDANA-loop. The three components of AnyDANA-loop are: 1) OpenAPS algorithm implemented in a smartphone (a version of AndroidAPS), 2) DANA-i™ insulin pump and, 3) Dexcom G6(R) continuous glucose monitor (CGM). The primary outcome measure is the percentage of time in target sensor glucose range (3.9 -10mmol/L). Secondary outcomes include psycho-social factors and platform performance. Analysis of online collective learning, characteristic of the open-source approach, is planned. 100 participants with T1D aged 7 – 70 years (age stratified into children/adolescents 7–15 years and adults 16–70 years), will be recruited from four sites in New Zealand. A 24-week continuation phase follows, to assess long-term safety.
has issue date	2020-05-30(xsd:dateTime)
bibo:doi	10.1007/s40200-020-00547-8
has license	no-cc
sha1sum (hex)	1c3937fedb1c1e3e7892832e9c701cd598d4fbfa
schema:url	https://doi.org/10.1007/s40200-020-00547-8
resource representing a document's title	CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes
has PubMed Central identifier	PMC7261211
schema:publication	J Diabetes Metab Disord
resource representing a document's body	covid:1c3937fedb1c1e3e7892832e9c701cd598d4fbfa#body_text
is schema:about of	named entity 'therapy' named entity 'expensive' named entity 'subsidy' named entity 'open-source' named entity 'augmented' named entity 'learning' named entity 'type 1 diabetes' named entity 'continuous glucose monitor' named entity 'sensor' named entity 'open label' named entity 'Community' named entity 'SITE' named entity 'ADULTS' named entity 'ALGORITHM' named entity 'METHODS' named entity 'OUR' named entity 'GLUCOSE' named entity 'LIMITED CAPACITY' named entity 'LARGE' named entity 'PARTICIPANTS' named entity 'IMPLEMENTED' named entity 'PAIRED' named entity 'STRATIFIED' named entity 'DELIVERY' named entity '100' named entity 'SAFETY' named entity 'COMMERCIAL' named entity 'stratified' named entity 'CREATE' named entity 'participants' named entity 'demonstrated' named entity 'performance' named entity 'data' named entity 'platform' named entity 'recruited' named entity 'insulin delivery' named entity 'open-source' named entity 'algorithm' named entity 'algorithm' named entity 'insulin pump' named entity 'open-source' named entity 'long-term' named entity 'New Zealand' named entity 'OpenAPS' named entity 'video conferencing' named entity 'T1D' named entity 'mEq/L' named entity 'mmol' named entity 'HbA1c' named entity 'T1D' named entity 'algorithm' named entity 'cloud based' named entity 'Australia' named entity 'SADE' named entity 'mmol/L' named entity 'RCT' named entity 'Artificial Pancreas' named entity 'kaupapa Māori' named entity 'statistically significant' named entity 'research staff' named entity 'public health' named entity 'REDCap' named entity 'iPhone' named entity 'diabetes' named entity 'EQ-5D' named entity 'algorithm' named entity 'World Health Organisation' named entity 'mmol/L' named entity 'glycaemic' named entity 'premenopausal' named entity 'quality of life' named entity 'urine' named entity 'diabetes' named entity 'EQ-5D' named entity 'diabetic complications'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software